Application Nr Approved Date Route Status External Links
NDA207946 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Invega Trinza ® (paliperidone Palmitate), A 3-Month Injection, Is Indicated For The Treatment Of Schizophrenia In Patients After They Have Been Adequately Treated With Invega Sustenna ® (1-Month Paliperidone Palmitate Extended-Release Injectable Suspension) For At Least Four Months [see Dosage And Administration (2.2) And Clinical Studies (14) ] . Invega Trinza ® , A 3-Month Injection, Is An Atypical Antipsychotic Indicated For The Treatment Of Schizophrenia In Patients After They Have Been Adequately Treated With Invega Sustenna ® (1-Month Paliperidone Palmitate Extended-Release Injectable Suspension) For At Least Four Months. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Paliperidone Palmitate PALIPERIDONE PALMITATE ZINC1481956

Comments